ATE471712T1 - Pharmazeutische zusammensetzung mit tetrahydrolipstatin - Google Patents

Pharmazeutische zusammensetzung mit tetrahydrolipstatin

Info

Publication number
ATE471712T1
ATE471712T1 AT07726152T AT07726152T ATE471712T1 AT E471712 T1 ATE471712 T1 AT E471712T1 AT 07726152 T AT07726152 T AT 07726152T AT 07726152 T AT07726152 T AT 07726152T AT E471712 T1 ATE471712 T1 AT E471712T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
tetrahydrolipstatin
containing tetrahydrolipstatin
carrageenan
Prior art date
Application number
AT07726152T
Other languages
English (en)
Inventor
Ljubin Tijana Stanic
Peterka Tanja Rozman
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE471712T1 publication Critical patent/ATE471712T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07726152T 2006-06-27 2007-06-25 Pharmazeutische zusammensetzung mit tetrahydrolipstatin ATE471712T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06013188A EP1872777A1 (de) 2006-06-27 2006-06-27 Pharmazeutische Zusammensetzung enthaltend Tetrahydrolipstatin
PCT/EP2007/005598 WO2008000420A1 (en) 2006-06-27 2007-06-25 Pharmaceutical composition comprising tetrahydrolipstatin

Publications (1)

Publication Number Publication Date
ATE471712T1 true ATE471712T1 (de) 2010-07-15

Family

ID=37142317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07726152T ATE471712T1 (de) 2006-06-27 2007-06-25 Pharmazeutische zusammensetzung mit tetrahydrolipstatin

Country Status (7)

Country Link
EP (2) EP1872777A1 (de)
AT (1) ATE471712T1 (de)
BR (1) BRPI0713062A2 (de)
CA (1) CA2656069A1 (de)
DE (1) DE602007007320D1 (de)
SI (1) SI2023901T1 (de)
WO (1) WO2008000420A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101833250B1 (ko) 2010-10-25 2018-03-02 한미사이언스 주식회사 저융점 활성 성분을 포함하는 구형 압출과립, 이를 포함하는 경구 투여용 정제 및 이의 제조 방법
UA122403C2 (uk) * 2014-12-17 2020-11-10 Емпрос Фарма Аб Композиція орлістату та акарбози з модифікованим вивільненням для лікування ожиріння і пов'язаних метаболічних порушень

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
AU2001281846B2 (en) * 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition

Also Published As

Publication number Publication date
EP2023901A1 (de) 2009-02-18
WO2008000420A1 (en) 2008-01-03
DE602007007320D1 (de) 2010-08-05
CA2656069A1 (en) 2008-01-03
BRPI0713062A2 (pt) 2012-04-10
SI2023901T1 (sl) 2011-02-28
EP1872777A1 (de) 2008-01-02
EP2023901B1 (de) 2010-06-23

Similar Documents

Publication Publication Date Title
WO2007016563A3 (en) Alcohol resistant pharmaceutical formulations
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
NL300889I2 (nl) Trifluridine in combinatie met tipiracilhydrochloride
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
TW200716206A (en) Unitary pharmaceutical dosage form
DE502005009109D1 (de) Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
EA201170512A1 (ru) Композиция для перорального введения
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
CY1115652T1 (el) Μορφη δοσολογιας που περιεχει δυο δραστικα φαρμακευτικα συστατικα μειγματος σε διαφορετικες φυσικες μορφες
ECSP066534A (es) Formas de dosificacion de oxicodona de liberacion controlada, orales, una vez al dia
EA200900105A1 (ru) Композиция, содержащая орнитин и фенилацетат или фенилбутират, для лечения печеночной энцефалопатии
DK1256343T3 (da) Flibanserin til behandlingen af extrapyramidale bevægelseslidelser
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
EP2234598C0 (de) Pharmazeutische zusammensetzungen mit mindestens einem proteinösen wirkstoff, der gegen verdauungsenzyme geschützt ist
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
EA201691869A1 (ru) Стабильная комбинированная фармацевтическая композиция
CY1107295T1 (el) Σταθεροποιηση στερεων φορμουλων φαρμακων του θυρεοειδους
DE60205905D1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
EA201390950A1 (ru) Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой
EA200900259A1 (ru) Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
DE602007007320D1 (de) Pharmazeutische zusammensetzung mit tetrahydrolipstatin
EA201290378A1 (ru) Композиции, содержащие нестероидные противовоспалительные лекарственные средства

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties